Tauroursodeoxycholate reduces ischemic damage in human allografts: A biochemical and ultrastructural study

被引:8
作者
Falasca, L
Tisone, G
Orlando, G
Baiocchi, L
Vennerecci, G
Anselmo, A
Torri, E
Di Paolo, D
Strati, F
Casciani, CU
Angelico, M
机构
[1] Univ Roma Tor Vergata, Dept Surg, Liver Tranplantat Ctr, Rome, Italy
[2] Univ Roma Tor Vergata, Div Gastroenterol & Pathol, Rome, Italy
关键词
D O I
10.1016/S0041-1345(99)00872-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:49 / 50
页数:2
相关论文
共 4 条
[1]  
HERTL M, 1997, HEPATOLOGY, V26
[2]   Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis [J].
Setchell, KDR ;
Rodrigues, CMP ;
Podda, M ;
Crosignani, A .
GUT, 1996, 38 (03) :439-446
[3]  
STRASBERG RM, 1997, LIVER TRANSPL SUR S1, V3, pS1
[4]   SELECTING THE DONOR LIVER - RISK-FACTORS FOR POOR FUNCTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION [J].
STRASBERG, SM ;
HOWARD, TK ;
MOLMENTI, EP ;
HERTL, M .
HEPATOLOGY, 1994, 20 (04) :829-838